Making headway in anticoagulant and antiplatelet therapy
被引:5
|
作者:
Fareed, Jawed
论文数: 0引用数: 0
h-index: 0
机构:
Loyola Univ, Med Ctr, Hemostasis & Thrombosis Res Labs, Maywood, IL 60153 USALoyola Univ, Med Ctr, Hemostasis & Thrombosis Res Labs, Maywood, IL 60153 USA
Fareed, Jawed
[1
]
机构:
[1] Loyola Univ, Med Ctr, Hemostasis & Thrombosis Res Labs, Maywood, IL 60153 USA
Despite favourable results in pivotal clinical trials involving novel direct oral anticoagulants, vitamin K antagonists remain the most commonly prescribed anticoagulant. Newer oral anticoagulants are slated for a wide range of additional indications, and specific antidotes to neutralize associated bleeding complications are currently under development.
机构:
Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
Harvard Med Sch, Boston, MA USABrigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA